Mikkel Højlund

1.3k total citations · 1 hit paper
44 papers, 608 citations indexed

About

Mikkel Højlund is a scholar working on Psychiatry and Mental health, Pediatrics, Perinatology and Child Health and Clinical Psychology. According to data from OpenAlex, Mikkel Højlund has authored 44 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Psychiatry and Mental health, 7 papers in Pediatrics, Perinatology and Child Health and 6 papers in Clinical Psychology. Recurrent topics in Mikkel Højlund's work include Schizophrenia research and treatment (28 papers), Bipolar Disorder and Treatment (13 papers) and Mental Health and Psychiatry (5 papers). Mikkel Højlund is often cited by papers focused on Schizophrenia research and treatment (28 papers), Bipolar Disorder and Treatment (13 papers) and Mental Health and Psychiatry (5 papers). Mikkel Højlund collaborates with scholars based in Denmark, United States and Germany. Mikkel Højlund's co-authors include Christoph U. Correll, Jesper Hallas, Kjeld Andersen, Lars Christian Lund, Anton Pottegård, Marco Solmi, Daniel Pilsgaard Henriksen, Povl Munk‐Jørgensen, Jacob Harbo Andersen and Lon S. Schneider and has published in prestigious journals such as BMJ, Thorax and Schizophrenia Bulletin.

In The Last Decade

Mikkel Højlund

42 papers receiving 603 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Outcomes in people with eating disorders: a transdiagnostic and disorder‐specific systematic review, meta‐analysis and multivariable meta‐regression analysis

2024 95 citations Marco Solmi, Francesco Monaco et al. World Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikkel Højlund Denmark	15	291	162	81	50	49	44	608
Sermin Toto Germany	17	413 1.4×	147 0.9×	170 2.1×	94 1.9×	60 1.2×	65	796
Guido Di Sciascio Italy	16	282 1.0×	245 1.5×	58 0.7×	33 0.7×	113 2.3×	35	630
Maria C. Catalano United States	16	269 0.9×	146 0.9×	98 1.2×	100 2.0×	65 1.3×	52	755
Jan McKendrick United States	13	247 0.8×	64 0.4×	74 0.9×	36 0.7×	45 0.9×	26	640
Nicola Poloni Italy	14	226 0.8×	156 1.0×	64 0.8×	32 0.6×	23 0.5×	40	502
Tania M Wilkins United States	10	224 0.8×	154 1.0×	190 2.3×	26 0.5×	94 1.9×	18	893
Mary Weber United States	11	387 1.3×	131 0.8×	72 0.9×	34 0.7×	13 0.3×	28	789
Ola Granström Sweden	8	474 1.6×	190 1.2×	56 0.7×	15 0.3×	31 0.6×	13	722
Maëlys Touya United States	11	368 1.3×	86 0.5×	110 1.4×	43 0.9×	80 1.6×	29	593
S. K. Mattoo India	15	165 0.6×	176 1.1×	72 0.9×	11 0.2×	54 1.1×	46	642

Countries citing papers authored by Mikkel Højlund

Since Specialization

Citations

This map shows the geographic impact of Mikkel Højlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikkel Højlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikkel Højlund more than expected).

Fields of papers citing papers by Mikkel Højlund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikkel Højlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikkel Højlund. The network helps show where Mikkel Højlund may publish in the future.

Co-authorship network of co-authors of Mikkel Højlund

This figure shows the co-authorship network connecting the top 25 collaborators of Mikkel Højlund. A scholar is included among the top collaborators of Mikkel Højlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikkel Højlund. Mikkel Højlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Højlund, Mikkel, et al.. (2025). Excess cardiometabolic risk in children and adolescents initiating antipsychotic treatment compared to young adults: results from a nationwide cohort study. World Psychiatry. 24(1). 103–112. 5 indexed citations

Højlund, Mikkel, Christopher Rohde, Christiane Gasse, et al.. (2025). Antipsychotic polypharmacy in patients with schizophrenia between 1999 and 2024 in Denmark: Prevalence, time trends, and combinations. European Neuropsychopharmacology. 100. 4–12. 1 indexed citations

Reilev, Mette, Jacob Harbo Andersen, Mikkel Højlund, et al.. (2025). Initiation and Discontinuation of Psychotropic Drugs Relative to Suicidal Behavior: A Danish Registry‐Based Study. Acta Psychiatrica Scandinavica. 151(6). 698–708.

Solmi, Marco, Francesco Monaco, Mikkel Højlund, et al.. (2024). Outcomes in people with eating disorders: a transdiagnostic and disorder‐specific systematic review, meta‐analysis and multivariable meta‐regression analysis. World Psychiatry. 23(1). 124–138. 95 indexed citations breakdown →

Danielsen, Andreas Aalkjær, et al.. (2024). The risk of diabetes and HbA1c deterioration during antipsychotic drug treatment: A Danish two‐cohort study among patients with first‐episode schizophrenia. Acta Psychiatrica Scandinavica. 151(1). 69–80. 1 indexed citations

Fabiano, Nicholas, et al.. (2024). Efficacy, tolerability, and safety of xanomeline-trospium chloride for schizophrenia: A systematic review and meta-analysis. European Neuropsychopharmacology. 92. 62–73. 14 indexed citations

Schoretsanitis, Georgios, Christoph U. Correll, Agorastos Agorastos, et al.. (2024). The European psychiatric association (EPA) – early career psychiatrists committee survey on trainees’ and early-career psychiatrists’ attitudes towards therapeutic drug monitoring (TDM) use and utility during antipsychotic treatment. The World Journal of Biological Psychiatry. 25(6). 342–351. 3 indexed citations

Correll, Christoph U., Mikkel Højlund, Christine Graham, et al.. (2023). Weight Gain and Metabolic Changes in Patients With First-Episode Psychosis or Early-Phase Schizophrenia Treated With Olanzapine: A Meta-Analysis. The International Journal of Neuropsychopharmacology. 26(7). 451–464. 11 indexed citations

Højlund, Mikkel, et al.. (2023). Neonatal and maternal outcomes with elective cesarean section compared to induction of labor in twin pregnancies: A prospective cohort study. European Journal of Obstetrics & Gynecology and Reproductive Biology. 286. 85–89. 1 indexed citations

10.

Kristensen, Kasper Bruun, Lars Christian Lund, Peter Bjødstrup Jensen, et al.. (2022). Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions. Clinical Epidemiology. Volume 14. 567–579. 24 indexed citations

11.

Højlund, Mikkel, Lárus S. Guðmundsson, Jacob Harbo Andersen, et al.. (2022). Use of benzodiazepines and benzodiazepine‐related drugs in the Nordic countries between 2000 and 2020. Basic & Clinical Pharmacology & Toxicology. 132(1). 60–70. 15 indexed citations

12.

Højlund, Mikkel, Henrik Støvring, Kjeld Andersen, Christoph U. Correll, & Jesper Hallas. (2022). Impact of low‐dose quetiapine‐use on glycosylated hemoglobin, triglyceride and cholesterol levels. Acta Psychiatrica Scandinavica. 147(1). 105–116. 9 indexed citations

13.

Rohde, Christopher, Mikkel Højlund, Christiane Gasse, et al.. (2022). Psychopharmacological treatment patterns prior to a schizophrenia diagnosis: A Danish nationwide study. Schizophrenia Research. 246. 268–276. 2 indexed citations

14.

Davidsen, Jesper Rømhild, Christian B. Laursen, Mikkel Højlund, et al.. (2021). Lung Ultrasound to Phenotype Chronic Lung Allograft Dysfunction in Lung Transplant Recipients. A Prospective Observational Study. Journal of Clinical Medicine. 10(5). 1078–1078. 6 indexed citations

15.

Jacobsen, Niels, et al.. (2021). Diagnostic accuracy of focused deep venous, lung, cardiac and multiorgan ultrasound in suspected pulmonary embolism: a systematic review and meta-analysis. Thorax. 77(7). 679–689. 26 indexed citations

16.

Højlund, Mikkel, et al.. (2021). How to Estimate QT Interval in Patients With Left or Right Bundle Branch Block. Journal of Clinical Psychopharmacology. 41(3). 323–326. 2 indexed citations

17.

Højlund, Mikkel, Jacob Harbo Andersen, Kjeld Andersen, Christoph U. Correll, & Jesper Hallas. (2021). Use of antipsychotics in Denmark 1997–2018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses. Epidemiology and Psychiatric Sciences. 30. e28–e28. 32 indexed citations

18.

Højlund, Mikkel, et al.. (2021). Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials. The Lancet Psychiatry. 8(6). 471–486. 36 indexed citations

19.

Højlund, Mikkel, et al.. (2020). Second-generation antipsychotics and the risk of chronic kidney disease: a population-based case-control study. BMJ Open. 10(8). e038247–e038247. 21 indexed citations

20.

Højlund, Mikkel, et al.. (2018). Obstructive hydrocephalus caused by colloid cyst presenting as a schizophrenia-like psychosis. BMJ Case Reports. 2018. bcr–2017. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact